Skip to main content
. 2019 Feb 12;10:144. doi: 10.3389/fmicb.2019.00144

Figure 2.

Figure 2

Percentage viability of HeLa cells when treated with supernatants of each isolate as determined by the WST-1 assay. Viability was calculated as ratio of corrected absorbance of solution when HeLa cells were treated with supernatants to the ratio of corrected absorbance of solution when HeLa cells were treated with BHI (i.e., negative control), converted to percentages. The columns represent the mean viabilities, while the error bars represent standard deviations for 12 technical replicates. Any two bars that do not share a common alphabetic character had significantly different percentage viability values (P < 0.05).

HHS Vulnerability Disclosure